X
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

ICYMI: More than 60 PhRMA company scientists visit Capitol Hill

By Andrew Powaleny  |    September 30, 2016
Last week, PhRMA brought more than 60 member company researchers and scientists to Capitol Hill for a biopharmaceutical researcher fly-in. The fly-in highlighted the important science that’s...   Read More

Eradication of measles highlights the promise of vaccines in development

By Hannah Mooney  |    September 29, 2016
On September 27, the Pan American Health Organization (PAHO) alongside the World Health Organization (WHO) announced that the Region of the Americas is the first region in the world to have...   Read More

Celebrating hope for patients and families on World Heart Day 2016

By Hannah Mooney  |    September 29, 2016
My heart lives in Portland, Ore. The reason I do my work is there too. That’s where I grew up and where I saw my grandfather earlier this month. If you ask him how he is doing, he’ll say, “I’m...   Read More

4 recommendations for ICER

By Lauren Neves  |    September 26, 2016
For years, PhRMA has supported policies that ensure health care decisions are grounded in the best available evidence. In our policy solutions for delivering innovative treatments to patients...   Read More

Medicare Monday: New Part D study highlights benefit of switching plans

By Allyson Funk  |    September 26, 2016
With open enrollment beginning on October 15, it’s important for consumers to have adequate information to make the right decision about their health coverage and whether or not they should stay...   Read More

340B Spotlight: Trends in shifting site of care

By Rachel Licata  |    September 21, 2016
Research has shown once health care services shift from a provider’s office to a hospital, treatment costs for payers and patients increase. One way hospitals drive this site of care shift is...   Read More

New Survey: Patients’ share of health care costs continues to grow

By Allyson Funk  |    September 20, 2016
As we’ve highlighted before, a growing body of research continues to raise red flags about the implications of high cost sharing and patients’ ability to access affordable care – even if they have...   Read More

Patient voices missing from media conversation about prescription drug abuse

By Caitlin Carroll  |    September 19, 2016
Confronting and curtailing opioid abuse in America is a top public health priority and one to which PhRMA remains deeply committed. Mandating prescriber training, using state-based databases to...   Read More

Who gets a seat at ICER’s table? Hint: It’s not patients

By Holly Campbell  |    September 19, 2016
As we continue the move toward a value-driven health care system, efforts to develop tools supporting patient decision-making will play a central role. These tools, including emerging value...   Read More

Medicare Monday: New study highlights impact of variability in Medication Therapy Management programs

By Carolyn Ha  |    September 19, 2016
It’s almost the time of year for seniors to review their medications and select a Part D plan that best meets their needs. Included in Medicare Part D is the opportunity for qualifying...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates